This protocol incorporates decisions taken by the EUROCARE Steering Committee in Utrecht on 12 December 2008, and the meeting of the EUROCARE Working Group in Genova, 10-12 March 2009.
Major changes in European cancer patient survival in the decade following 2000 are expected as a result of the introduction of new targeted treatments and new diagnostic tools. In several European countries, changes in health care systems and implementation of national cancer plans and screening programmes are also likely to have influenced patient survival.
EUROCARE-5 will update and expand the EUROCARE database in order to:
- continue monitoring population-based cancer survival in Europe by country, region, age, time and sex
- enlarge the coverage of European population
- study long-term survival and temporal trends in survival
- use the available information on stage at diagnosis and treatment to interpret survival variations and time trends
- use the period survival method to provide short-term predictions of survival based on the most recent follow-up data
- update the estimates of cancer prevalence
- estimate the proportion of cancer patients who are cured of their disease
- estimate the number and proportion of avoidable deaths
- make datasets available to participating EUROCARE centres for further analyses: the Co-ordinating Centre and the Data Analysis Group will assist researchers interested in such studies
EUROCARE-5 study protocol – 2010 Call for data
